688289 聖湘生物
按盤價 
16.820 +1.430 (+9.292%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.697 | 2.771 | 3.816 | 4.948 | 27.929 |
| 總資產報酬率 ROA (%) | 0.520 | 2.195 | 3.231 | 4.127 | 23.817 |
| 投入資產回報率 ROIC (%) | 0.562 | 2.395 | 3.627 | 4.845 | 27.468 | 邊際利潤分析 |
| 銷售毛利率 (%) | 73.314 | 75.786 | 77.912 | 71.539 | 58.834 |
| 營業利潤率 (%) | 11.905 | 12.383 | 19.051 | 42.444 | 36.274 |
| 息稅前利潤/營業總收入 (%) | 9.927 | 6.762 | 12.024 | 35.450 | 35.123 |
| 淨利潤/營業總收入 (%) | 9.556 | 9.377 | 15.519 | 34.571 | 30.025 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 124.174 | 140.077 | 68.961 | 6.158 | 109.765 |
| 價值變動淨收益/利潤總額(%) | -13.200 | -3.806 | -7.842 | 76.881 | 3.422 |
| 營業外收支淨額/利潤總額(%) | -1.863 | -16.099 | -6.587 | -4.138 | -1.031 | 償債能力分析 |
| 流動比率 (X) | 4.263 | 4.373 | 7.670 | 6.473 | 4.788 |
| 速動比率 (X) | 3.897 | 4.030 | 7.150 | 6.063 | 4.562 |
| 資產負債率 (%) | 24.746 | 24.527 | 14.622 | 12.175 | 18.106 |
| 帶息債務/全部投入資本 (%) | 17.661 | 17.306 | 5.847 | 1.050 | 0.483 |
| 股東權益/帶息債務 (%) | 455.967 | 467.045 | 1,587.020 | 9,285.780 | 20,361.485 |
| 股東權益/負債合計 (%) | 301.355 | 304.552 | 575.768 | 699.630 | 451.575 |
| 利息保障倍數 (X) | -5.638 | -1.732 | -2.056 | -6.679 | -44.984 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 132.683 | 126.189 | 150.476 | 351.351 | 57.791 |
| 存貨周轉天數 (天) | 330.334 | 365.202 | 430.019 | 459.635 | 49.133 |
| 備註： | 即時報價更新時間為 13/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
